Stock XRTX XORTX THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Market Closed - Toronto S.E.
Other stock markets
 03:59:59 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.07 CAD +12.43% Intraday chart for XORTX Therapeutics Inc. 0.00% +40.34%
Apr. 22 XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal MT
Apr. 08 XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors CI

Evolution of the average Target Price on XORTX Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

b9c123c579.iY4DtY8oh9V--tolSuY_afRcavCHPA4HWG8sXNASlCA.wL1l8fhbs5gwkYlJeKtJEZgkL6LCVzc0bF4cZYcrwGfo5nvsyB3pljKS7g~b42f04ffa76c1e2b33f227070634686e

Analyst Recommendations on XORTX Therapeutics Inc.

Wall Street Set for Losses as Rate Hike Fears Resurface Ahead of Jackson Hole MT
Alliance Global Partners Initiates XORTX Therapeutics at Buy Rating With $11 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.07
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering XORTX Therapeutics Inc.

Alliance Global Partners

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XRTX Stock
  4. Consensus XORTX Therapeutics Inc.